UBI Pharma Dividends and Buybacks
Dividend criteria checks 0/6
UBI Pharma does not currently pay a dividend.
Key information
0%
Dividend yield
-3.8%
Buyback Yield
| Total Shareholder Yield | -3.8% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NT$0.0321 |
| Payout ratio | 0% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 6562's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 6562's dividend payments have been increasing.
Dividend Yield vs Market
| UBI Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (6562) | 0% |
| Market Bottom 25% (TW) | 1.7% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Biotechs) | 2.4% |
| Analyst forecast (6562) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate 6562's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 6562's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: 6562 is not paying a notable dividend for the TW market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 6562 has not reported any payouts.